For people taking both tirzepatide and an SGLT2 inhibitor, which some diabetes treatment plans do include, any UTI risk comes from the SGLT2 inhibitor, not the tirzepatide
Record the drug name (cyanocobalamin), concentration (mcg/mL), volume drawn, route (IM or SQ), injection site, and the administering clinician
While the exact mechanism isnt fully understood, it may relate to GLP-1s effects on fluid balance, autonomic nervous system regulation, or as a secondary consequence of other side effects like nausea or reduced fluid intake
I think the plateau conversation is one of the most important topics in weight management
Simple timing framework Baseline Discuss baseline labs before starting, especially with diabetes, kidney disease, gallbladder history, pancreatitis history, liver disease, or cardiovascular concerns